Giovanni Leo

Giovanni Leo serves as Venture Partner at Innogest Capital. He has been VP of R&D of St Jude Medical since the acquisition of Endosense in 2013 which he co-founded to develop novel technology for the catheter ablation treatment of cardiac arrhythmias. Prior to Endosense, Giovanni was the director of the Geneva offices for Acrostak Corp., a Boston-Scientific-funded medical device company that developed the only European system for vascular brachytherapy. He was also co-founder of Isotopes and Metals Ltd., an emerging medical device company focused on technology for prostate and gynecological brachytherapy. Giovanni previously held a software quality manager position at LeCroy Corp. as well as a CERN fellowship in the Accelerator Technology, Industrial Controls Group. Giovanni earned an Executive MBA in Management and Corporate Finance from the HEC of Lausanne, following a degree in management engineering from Politecnico of Milano, Italy.